<?xml version='1.0' encoding='UTF-8'?>
<!-- Created by Xince -->
<xbrli:xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:tpia="http://tpia/20250930" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025">
  <link:schemaRef xlink:href="./TPIA_taxonomy_Q3_2024_2025.zip/TPIA_taxonomy_Q3_2024_2025/TPIA-20251231.xsd" xlink:type="simple"/>
  <xbrli:context id="c">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c1">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c3">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c4">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c5">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c6">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c7">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-07-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c8">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-04-01</xbrli:startDate>
      <xbrli:endDate>2023-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c9">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-07-01</xbrli:startDate>
      <xbrli:endDate>2023-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c10">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c11">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c12">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c13">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderCMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c14">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c15">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderBMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c16">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c17">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c18">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c19">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-07-01</xbrli:startDate>
      <xbrli:endDate>2023-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c21">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c22">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c23">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c24">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-07-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c25">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c26">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-04-01</xbrli:startDate>
      <xbrli:endDate>2023-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c27">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-04-01</xbrli:startDate>
      <xbrli:endDate>2024-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c28">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c29">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tpia:N2020ProduceSalesIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2021-01-19</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c32">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c33">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c34">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderFMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c35">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tpia:CeoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-07-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c36">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tpia:CeoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-07-01</xbrli:startDate>
      <xbrli:endDate>2023-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c37">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-04-01</xbrli:startDate>
      <xbrli:endDate>2024-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c38">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-07-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c39">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderBMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c40">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-04-01</xbrli:startDate>
      <xbrli:endDate>2024-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c41">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c42">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c43">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderFMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c44">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c45">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c46">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c47">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c48">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderDMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c49">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-04-01</xbrli:startDate>
      <xbrli:endDate>2023-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c50">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-09-30</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c51">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c52">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-12-31</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c53">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-04-01</xbrli:startDate>
      <xbrli:endDate>2024-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c54">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c55">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c56">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c57">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c58">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c59">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c60">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c61">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c62">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-04-01</xbrli:startDate>
      <xbrli:endDate>2024-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c63">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c64">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c65">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c66">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-11-14</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c67">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c68">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-04-01</xbrli:startDate>
      <xbrli:endDate>2023-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c69">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-04-01</xbrli:startDate>
      <xbrli:endDate>2024-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c70">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c71">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c72">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderDMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c73">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c74">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tpia:CeoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c75">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-07-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c76">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c77">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c78">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c79">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tpia:ConvertibleDebt1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c80">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderFMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c81">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-04-01</xbrli:startDate>
      <xbrli:endDate>2023-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c82">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tpia:ConvertibleDebt1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c83">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tpia:WarrantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c84">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c85">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-04-01</xbrli:startDate>
      <xbrli:endDate>2023-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c86">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tpia:WarrantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c87">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c88">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c89">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderDMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c90">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c91">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c92">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-07-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c93">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c94">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c95">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderCMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c96">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c97">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c98">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c99">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderCMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c100">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c101">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c102">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c103">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderBMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c104">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c105">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c106">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c107">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c108">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2022-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c109">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c110">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-07-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c111">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2023-01-01</xbrli:startDate>
      <xbrli:endDate>2023-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c112">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">tpia:LenderEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2024-01-01</xbrli:startDate>
      <xbrli:endDate>2024-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c113">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tpia:BoardCompensationMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2024-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c114">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001763329</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tpia:BoardCompensationMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2023-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="usd">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="usd1">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <dei:EntityFileNumber id="f" contextRef="c">000-56022</dei:EntityFileNumber>
  <dei:EntityAddressCityOrTown id="f1" contextRef="c">Miami</dei:EntityAddressCityOrTown>
  <us-gaap:IntangibleAssetsNetIncludingGoodwill id="f2" decimals="INF" contextRef="c1" unitRef="usd">2000000.0</us-gaap:IntangibleAssetsNetIncludingGoodwill>
  <us-gaap:DebtDisclosureTextBlock id="f3" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;NOTE 6 – PROMISSORY AND CONVERTIBLE NOTES&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On August 27, 2021, the Company issued a lender (“Lender A”) a convertible note payable with principal of $500,000 and an original issue discount of $50,000. The note matures after 24 months and has an effective interest rate of 8%. As of September 30, 2024, and December 31, 2023, this convertible note payable was in default and therefore classified as a current liability. Default interest accrues at a rate of 20% upon default, and the default conversion price is $0.75 per share. As of September 30, 2024, and December 31, 2023, the Company had an outstanding principal amount of $500,000 due to this lender as a result of the note.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On September 17, 2021, the Company issued a lender (“Lender B”) a convertible note payable with principal of $55,000 and an original issue discount of $5,000. The note matures after 24 months and has an effective interest rate of 8%. As of September 30, 2024, and December 31, 2023, this convertible note payable was in default and therefore classified as a current liability. Default interest accrues at a rate of 20% upon default, and the default conversion price is $0.75 per share. As of September 30, 2024, and December 31, 2023, the Company had an outstanding principal amount of $55,000 due to this lender as a result of the note.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On October 27, 2021, the Company issued a lender (“Lender C”) a convertible note payable with principal of $220,000 and an original issue discount of $20,000. The note matures after 24 months and has an effective interest rate of 8%. As of September 30, 2024, and December 31, 2023, this convertible note payable was in default and therefore classified as a current liability. Default interest accrues at a rate of 20% upon default, and the default conversion price is $0.75 per share. As of September 30, 2024, and December 31, 2023, the Company had an outstanding principal amount of $220,000 due to this lender as a result of the note.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On January 21, 2022, the Company issued a lender (“Lender E”) a convertible note payable with principal of $325,000 and an original issue discount of $75,000. The note matures after 24 months and has an effective interest rate of 8%. As of September 30, 2024, and December 31, 2023, this convertible note payable was in default and therefore classified as a current liability. Default interest accrues at a rate of 20% upon default, and the default conversion price is $0.975 per share. As of September 30, 2024, and December 31, 2023, the Company had an outstanding principal amount of $325,000 due as a result of this note. &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On January 30th, 2024, the Company signed an agreement with a major shareholder (“Lender F”) for a $165,000 note payable. The note accrues interest at a rate of 1.75% compounded annually and has a maturity date of January 30, 2025 (Note 5 – Related Party Transactions).&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;During the year ended December 31, 2021, the Company issued a convertible notes payable. During the year ended December 31, 2022, the note was converted into shares of the Company’s common stock in accordance with the terms of the note agreement. Following the conversion, $2,407 of accrued interest remained outstanding and owed to the note holder (“Lender D”).&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The following tables reflects a summary of the outstanding principal and interest by each lender and their respective maturity date as of September 30, 2024 and December 31, 2023:&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="5" style="width:38.84%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;September 30, 2024&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="5" style="width:36.76%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Maturity Date&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Total Outstanding***&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.3%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Principal&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.68%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Total Outstanding***&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.22%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Principal&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:7.68%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender A&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;8/27/2023&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;725,792&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; $&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;500,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;225,792&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; $&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;626,884&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; $&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;500,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;126,884&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender B&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;9/27/2023&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;78,671&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;55,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;23,671&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;67,950&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;55,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;12,950&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender C&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;10/27/2023&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;309,089&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;220,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;89,089&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;266,968&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;220,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;46,968&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender D&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;10/21/2023&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;2,407&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;2,407&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;2,407&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;2,407&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender E&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;1/21/2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;431,698&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;325,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;106,698&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;375,504&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;325,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;50,504&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;b&gt;&lt;i&gt;Lender F&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;1/30/2025&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;166,930&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;165,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;1,930&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0"&gt;&lt;span style="font-size:8pt"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; $&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,714,587&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt; $&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.3%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,265,000&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.68%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;449,587&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt; $&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,339,714&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt; $&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.22%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,100,000&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:7.68%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;239,714&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="11" style="width:78.08%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;&lt;b&gt;&lt;i&gt;*** - Total Outstanding = Principal + Interest as of September 30, 2024 and December 31, 2023&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;During the nine months ended September 30, 2024 and 2023, the Company recorded debt discount amortization expense in the amount of $9,349 and $386,403, respectively. As of September 30, 2024, the Company had an unamortized debt discount balance of $0.&lt;/p&gt;
</us-gaap:DebtDisclosureTextBlock>
  <tpia:AverageNumberOfCommonShareOutstandingBasicAndDiluted id="f4" decimals="INF" contextRef="c" unitRef="shares">12665932.0</tpia:AverageNumberOfCommonShareOutstandingBasicAndDiluted>
  <us-gaap:NetIncomeLoss id="f5" decimals="128" contextRef="c2" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="f6" decimals="INF" contextRef="c3" unitRef="usd">-303004.0</us-gaap:NetIncomeLoss>
  <us-gaap:PreferredStockSharesOutstanding id="f7" decimals="INF" contextRef="c4" unitRef="shares">1.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:StockholdersEquity id="f8" decimals="INF" contextRef="c5" unitRef="usd">-2924927.0</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="f9" decimals="128" contextRef="c6" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <us-gaap:NetIncomeLoss id="f10" decimals="INF" contextRef="c7" unitRef="usd">-460144.0</us-gaap:NetIncomeLoss>
  <us-gaap:ShareBasedCompensation id="f11" decimals="128" contextRef="c8" unitRef="usd">0.0</us-gaap:ShareBasedCompensation>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock id="f12" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:9.94%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Underlying&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:20.24%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:27.56%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Weighted Average Term (Years)&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Warrants outstanding at January 1, 2023&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1,542,502&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.65&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1.29&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Granted&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1,922&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.01&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.38&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Exercised&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Forfeited/Expired&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;(333,333&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;1.50&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Warrants outstanding at September 30, 2023&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1,211,091&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.42&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.15&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Warrants outstanding at January 1, 2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;666,666&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1.50&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.80&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Granted&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Exercised&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Forfeited/Expired &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;(333,333&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1.50&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Warrants outstanding and exercisable at September 30, 2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;333,333&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$ &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1.50&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.19&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:AssetAcquisitionTextBlock id="f13" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;NOTE 4 – ASSETS ACQUSITION&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;On November 28, 2023, the Company entered into an asset sale and purchase agreement with Philon Labs, LLC. (the “seller” or “Philon Labs”) for consideration of approximately $2,000,000 in exchange for the intangible assets. The purpose of the assets purchase was to begin the Company’s transition to a growth-oriented company that applies advanced engineering and design techniques to new products. The entire purchase consideration was allocated as fair value to the intellectual property acquired from the seller. The $2,000,000 was to be paid through the issuance of a new series of Preferred Stock. As of September 30, 2024, the consideration has not been issued to the seller and is recorded as shares to be issued on the consolidated balance sheet. The Company has analyzed the shares to be issued balance and determined that they are liabilities in accordance with &lt;i&gt;ASC 480 – Distinguishing Liabilities from Equity&lt;/i&gt;. Subsequent to September 30, 2024, the Company issued 200,000 shares of Series B Preferred Stock to the seller as satisfaction of the intangible assets’ consideration (Note 10 – Subsequent Events).&lt;/p&gt;
&lt;p style="font:12pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;The acquired intangible assets are being amortized over their estimated useful lives of 3 years.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;Intangible assets as of September 30, 2024 and December 31, 2023, are as follows:&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="width:50.02%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:24.7%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.86%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="3" style="width:22.42%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:50.02%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:24.7%;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.86%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="3" style="width:22.42%;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:50.02%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Intellectual property&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.52%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:22.18%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;2,000,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.86%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.86%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:18.28%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;2,000,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.28%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:50.02%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Less: accumulated amortization&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.52%;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:22.18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt; (560,219&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.86%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;) &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.86%;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:18.28%;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt; (60,219&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.28%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;)&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:50.02%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Intangible assets, net&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.52%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:22.18%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1,439,781&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.86%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.86%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:18.28%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1,939,781&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.28%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;Amortization expense from intangible assets was $500,000 and $0 for the nine months ended September 30, 2024, and 2023. &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin-top:0pt;margin-bottom:8pt;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;Future amortization expense from intangible assets as of September 30, 2024, were as follows:&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;For the Year Ended,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:77.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Remainder of 2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.06%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:17.98%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;167,883&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;2025&lt;/p&gt;
&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;666,058&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;2026&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;605,839&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Thereafter&lt;/p&gt;
&lt;/td&gt;&lt;td style="padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;padding-bottom:2.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Total remaining amortization expense&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;padding-bottom:2.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1,439,781&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;padding-bottom:2.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:AssetAcquisitionTextBlock>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock id="f14" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Cash&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The Company considers all highly liquid investments with original maturities at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents include bank demand deposits, marketable securities with maturities of three months or less at purchase, and money market funds that invest primarily in certificates of deposits, commercial paper and U.S. government and U.S. government agency obligations. Cash equivalents are reported at fair value. The Company maintains its cash balances with a bank whose balance is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. The Company monitors the cash balances held in its bank accounts, and as of September 30, 2024, and December 31, 2023, did not have any concerns regarding cash balances which exceeded the insured amounts.&lt;/p&gt;
</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:NonoperatingIncomeExpense id="f15" decimals="INF" contextRef="c9" unitRef="usd">-143279.0</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:StockholdersEquity id="f16" decimals="INF" contextRef="c10" unitRef="usd">-1194352.0</us-gaap:StockholdersEquity>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="f17" decimals="INF" contextRef="c11" unitRef="usd1">0.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:StockholdersEquity id="f18" decimals="128" contextRef="c4" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <us-gaap:IncomeTaxPolicyTextBlock id="f19" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The Company provides for income taxes using the asset and liability approach. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of September 30, 2024 and December 31, 2023, the Company had a full valuation allowance against its deferred tax assets.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;We adopted ASC 740-10-25, &lt;i&gt;Income Taxes—Recognition&lt;/i&gt;, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC 740-10-25, we may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. ASC 740-10-25 also provides guidance on derecognition, classification, interest and penalties on income taxes, and accounting in interim periods and requires increased disclosures. We had no material adjustments to our liabilities for unrecognized income tax benefits according to the provisions of ASC 740-10-25.&lt;/p&gt;
</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:DebtInstrumentMaturityDate id="f20" contextRef="c12">2023-08-27</us-gaap:DebtInstrumentMaturityDate>
  <tpia:ConvertibleDebtOutstanding id="f21" decimals="INF" contextRef="c13" unitRef="usd">266968.0</tpia:ConvertibleDebtOutstanding>
  <dei:EntityAddressStateOrProvince id="f22" contextRef="c">FL</dei:EntityAddressStateOrProvince>
  <us-gaap:SharesOutstanding id="f23" decimals="128" contextRef="c14" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <us-gaap:ConvertibleNotesPayable id="f24" decimals="INF" contextRef="c15" unitRef="usd">55000.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock id="f25" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#FFFFFF;width:80%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt;Intangible Assets, Net Categories&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:2%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Intellectual property&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;3 Years&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
  <dei:DocumentType id="f26" contextRef="c">10-Q</dei:DocumentType>
  <us-gaap:AccruedLiabilitiesCurrent id="f27" decimals="INF" contextRef="c16" unitRef="usd">239714.0</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AdjustmentForAmortization id="f28" decimals="128" contextRef="c17" unitRef="usd">0.0</us-gaap:AdjustmentForAmortization>
  <tpia:NetLossPerShareBasicAndDiluted id="f29" decimals="INF" contextRef="c17" unitRef="usd1">-0.06</tpia:NetLossPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss id="f30" decimals="128" contextRef="c18" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="f31" decimals="INF" contextRef="c19" unitRef="usd">-308700.0</us-gaap:NetIncomeLoss>
  <us-gaap:PreferredStockValue id="f32" decimals="128" contextRef="c20" unitRef="usd">0.0</us-gaap:PreferredStockValue>
  <us-gaap:InterestExpense id="f33" decimals="INF" contextRef="c17" unitRef="usd">462601.0</us-gaap:InterestExpense>
  <us-gaap:StockholdersEquity id="f34" decimals="INF" contextRef="c21" unitRef="usd">6873429.0</us-gaap:StockholdersEquity>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f35" decimals="INF" contextRef="c22" unitRef="usd1">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:OperatingExpenses id="f36" decimals="INF" contextRef="c17" unitRef="usd">427785.0</us-gaap:OperatingExpenses>
  <us-gaap:SharesOutstanding id="f37" decimals="128" contextRef="c23" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses id="f38" decimals="INF" contextRef="c24" unitRef="usd">379.0</tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="f39" decimals="INF" contextRef="c17" unitRef="usd">-68914.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:ConvertibleNotesPayable id="f40" decimals="INF" contextRef="c25" unitRef="usd">1265000.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:NetIncomeLoss id="f41" decimals="128" contextRef="c24" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="f42" decimals="128" contextRef="c26" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <dei:EntityAddressPostalZipCode id="f43" contextRef="c">33131</dei:EntityAddressPostalZipCode>
  <us-gaap:CommonStockParOrStatedValuePerShare id="f44" decimals="INF" contextRef="c16" unitRef="usd1">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <tpia:ExchangeOfCommonStockForSeriesAPreferredStock id="f45" decimals="INF" contextRef="c27" unitRef="usd">9794.0</tpia:ExchangeOfCommonStockForSeriesAPreferredStock>
  <us-gaap:StockholdersEquity id="f46" decimals="128" contextRef="c20" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <tpia:IntangibleAssetsAcquiredThroughPromiseToIssueShares id="f47" decimals="INF" contextRef="c" unitRef="usd">2000000.0</tpia:IntangibleAssetsAcquiredThroughPromiseToIssueShares>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="f48" decimals="INF" contextRef="c25" unitRef="shares">333333.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:CommonStockParOrStatedValuePerShare id="f49" decimals="INF" contextRef="c25" unitRef="usd1">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:PrepaidExpenseCurrent id="f50" decimals="128" contextRef="c16" unitRef="usd">0.0</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:OperatingIncomeLoss id="f51" decimals="INF" contextRef="c" unitRef="usd">-1137539.0</us-gaap:OperatingIncomeLoss>
  <us-gaap:StockholdersEquity id="f52" decimals="INF" contextRef="c28" unitRef="usd">-1428649.0</us-gaap:StockholdersEquity>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="f53" decimals="INF" contextRef="c25" unitRef="usd">-10317742.0</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:OperatingIncomeLoss id="f54" decimals="INF" contextRef="c9" unitRef="usd">-165421.0</us-gaap:OperatingIncomeLoss>
  <us-gaap:StockholdersEquity id="f55" decimals="INF" contextRef="c29" unitRef="usd">6917774.0</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesAuthorized id="f56" decimals="INF" contextRef="c25" unitRef="shares">467000000.0</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:ConvertibleNotesPayable id="f57" decimals="INF" contextRef="c13" unitRef="usd">220000.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:CommonStockSharesAuthorized id="f58" decimals="INF" contextRef="c16" unitRef="shares">100000000.0</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CashFDICInsuredAmount id="f59" decimals="INF" contextRef="c25" unitRef="usd">250000.0</us-gaap:CashFDICInsuredAmount>
  <us-gaap:NetIncomeLoss id="f60" decimals="INF" contextRef="c30" unitRef="usd">-303004.0</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="f61" decimals="128" contextRef="c6" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <tpia:ConvertibleDebtInterest id="f62" decimals="INF" contextRef="c15" unitRef="usd">23671.0</tpia:ConvertibleDebtInterest>
  <us-gaap:CommonStockSharesIssued id="f63" decimals="INF" contextRef="c25" unitRef="shares">5481619.0</us-gaap:CommonStockSharesIssued>
  <us-gaap:AccruedLiabilitiesAndOtherLiabilities id="f64" decimals="INF" contextRef="c25" unitRef="usd">792000.0</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage id="f65" decimals="INF" contextRef="c31" unitRef="pure">0.7577</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <tpia:ConvertibleDebtOutstanding id="f66" decimals="INF" contextRef="c32" unitRef="usd">725792.0</tpia:ConvertibleDebtOutstanding>
  <dei:EntityInteractiveDataCurrent id="f67" contextRef="c">Yes</dei:EntityInteractiveDataCurrent>
  <us-gaap:CommonStockSharesOutstanding id="f68" decimals="INF" contextRef="c25" unitRef="shares">5481619.0</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:IntangibleAssetsNetIncludingGoodwill id="f69" decimals="INF" contextRef="c16" unitRef="usd">1939781.0</us-gaap:IntangibleAssetsNetIncludingGoodwill>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="f70" decimals="INF" contextRef="c25" unitRef="usd">202358.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:AccruedLiabilitiesAndOtherLiabilities id="f71" decimals="INF" contextRef="c16" unitRef="usd">576000.0</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
  <us-gaap:PreferredStockSharesIssued id="f72" decimals="INF" contextRef="c22" unitRef="shares">0.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:NetIncomeLoss id="f73" decimals="128" contextRef="c33" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:CommonStockSharesIssued id="f74" decimals="INF" contextRef="c16" unitRef="shares">14896791.0</us-gaap:CommonStockSharesIssued>
  <us-gaap:NetIncomeLoss id="f75" decimals="INF" contextRef="c9" unitRef="usd">-308700.0</us-gaap:NetIncomeLoss>
  <tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShare id="f76" decimals="INF" contextRef="c8" unitRef="shares">38434.0</tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShare>
  <us-gaap:DebtInstrumentMaturityDate id="f77" contextRef="c34">2025-01-30</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="f78" decimals="128" contextRef="c17" unitRef="usd">0.0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <dei:EntityCentralIndexKey id="f79" contextRef="c">0001763329</dei:EntityCentralIndexKey>
  <dei:EntityRegistrantName id="f80" contextRef="c">Mycotopia Therapies, Inc.</dei:EntityRegistrantName>
  <us-gaap:StockholdersEquity id="f81" decimals="128" contextRef="c14" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <us-gaap:ShareBasedCompensation id="f82" decimals="INF" contextRef="c35" unitRef="usd">0.0</us-gaap:ShareBasedCompensation>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock id="f83" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Property and Equipment, Net&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Property and equipment are stated at cost. For financial reporting, we provide for depreciation using the straight-line method at rates based upon the estimated useful lives of the various assets. Depreciation expense was $498 and $747 for the nine months ended September 30, 2024, and 2023, respectively. The Company computes depreciation utilizing estimated useful lives, as stated below:&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#FFFFFF;width:80%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt;Property and Equipment, Net Categories&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:2%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Equipment&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;3 Years&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Management assesses property and equipment for impairment whenever there is an indicator of impairment. Impairment losses are evaluated if the estimated undiscounted cash flows from using the assets are less than carrying value. A loss is recognized when the carrying value of an asset exceeds its fair value. Management assessed and concluded that no impairment write-down would be necessary for the Company’s property and equipment as of September 30, 2024 and December 31, 2023.&lt;/p&gt;
</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <dei:CurrentFiscalYearEndDate id="f84" contextRef="c">--12-31</dei:CurrentFiscalYearEndDate>
  <us-gaap:CommonStockSharesOutstanding id="f85" decimals="INF" contextRef="c16" unitRef="shares">14896791.0</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:ShareBasedCompensation id="f86" decimals="INF" contextRef="c36" unitRef="usd">635.0</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice id="f87" decimals="INF" contextRef="c" unitRef="usd1">1.5</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <dei:AmendmentFlag id="f88" contextRef="c">false</dei:AmendmentFlag>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="f89" decimals="INF" contextRef="c17" unitRef="usd1">0.01</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:NetIncomeLoss id="f90" decimals="128" contextRef="c37" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <dei:DocumentFiscalYearFocus id="f91" contextRef="c">2024</dei:DocumentFiscalYearFocus>
  <us-gaap:ShareBasedCompensation id="f92" decimals="128" contextRef="c" unitRef="usd">0.0</us-gaap:ShareBasedCompensation>
  <us-gaap:ProceedsFromRelatedPartyDebt id="f93" decimals="INF" contextRef="c" unitRef="usd">165000.0</us-gaap:ProceedsFromRelatedPartyDebt>
  <tpia:ConvertibleDebtInterest id="f94" decimals="INF" contextRef="c25" unitRef="usd">449587.0</tpia:ConvertibleDebtInterest>
  <tpia:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm id="f95" decimals="128" contextRef="c" unitRef="pure">0.0</tpia:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm>
  <dei:DocumentFiscalPeriodFocus id="f96" contextRef="c">Q3</dei:DocumentFiscalPeriodFocus>
  <us-gaap:StockholdersEquity id="f97" decimals="128" contextRef="c23" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="f98" decimals="INF" contextRef="c25" unitRef="usd">560219.0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <tpia:NetLossPerShareBasicAndDiluted id="f99" decimals="INF" contextRef="c7" unitRef="usd1">-0.06</tpia:NetLossPerShareBasicAndDiluted>
  <tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses id="f100" decimals="INF" contextRef="c38" unitRef="usd">25871.0</tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="f101" decimals="INF" contextRef="c17" unitRef="usd">-890386.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:AssetAcquisitionTableTextBlock id="f102" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="width:50.02%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:24.7%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.86%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="3" style="width:22.42%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:50.02%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:24.7%;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.86%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="3" style="width:22.42%;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:50.02%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Intellectual property&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.52%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:22.18%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;2,000,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.86%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.86%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:18.28%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;2,000,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.28%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:50.02%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Less: accumulated amortization&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.52%;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:22.18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt; (560,219&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.86%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;) &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.86%;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:18.28%;border-bottom:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt; (60,219&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.28%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;)&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:50.02%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Intangible assets, net&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.52%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:22.18%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1,439,781&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.86%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.86%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:18.28%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1,939,781&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.28%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:AssetAcquisitionTableTextBlock>
  <tpia:ConvertibleDebtInterest id="f103" decimals="INF" contextRef="c13" unitRef="usd">46968.0</tpia:ConvertibleDebtInterest>
  <us-gaap:Liabilities id="f104" decimals="INF" contextRef="c16" unitRef="usd">4247723.0</us-gaap:Liabilities>
  <us-gaap:InterestExpense id="f105" decimals="INF" contextRef="c7" unitRef="usd">74887.0</us-gaap:InterestExpense>
  <us-gaap:OperatingExpenses id="f106" decimals="INF" contextRef="c7" unitRef="usd">385257.0</us-gaap:OperatingExpenses>
  <tpia:ConvertibleDebtOutstanding id="f107" decimals="INF" contextRef="c39" unitRef="usd">67950.0</tpia:ConvertibleDebtOutstanding>
  <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet id="f108" decimals="INF" contextRef="c" unitRef="usd">-209873.0</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
  <tpia:ExchangeOfCommonStockForSeriesAPreferredStock id="f109" decimals="128" contextRef="c40" unitRef="usd">0.0</tpia:ExchangeOfCommonStockForSeriesAPreferredStock>
  <tpia:ShareholderLoan id="f110" decimals="INF" contextRef="c25" unitRef="usd">2000000.0</tpia:ShareholderLoan>
  <us-gaap:ConvertibleNotesPayable id="f111" decimals="INF" contextRef="c32" unitRef="usd">500000.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:PreferredStockValue id="f112" decimals="128" contextRef="c41" unitRef="usd">0.0</us-gaap:PreferredStockValue>
  <us-gaap:StockholdersEquity id="f113" decimals="INF" contextRef="c42" unitRef="usd">-8960981.0</us-gaap:StockholdersEquity>
  <tpia:ConvertibleDebtOutstanding id="f114" decimals="INF" contextRef="c43" unitRef="usd">166930.0</tpia:ConvertibleDebtOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="f115" decimals="INF" contextRef="c7" unitRef="usd">-460144.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock id="f116" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-indent:-18pt;margin-left:18pt;color:#000000;text-align:justify"&gt;&lt;b&gt;NOTE 2 - GOING CONCERN&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. To date, the Company has generated no revenues, experienced negative operating cash flows and has incurred operating losses since inception. Management expects the Company to continue to fund its operations primarily through the issuance of debt or equity.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;For the nine months ended September 30, 2024, the Company incurred a net loss of $1,356,761, had negative cash flows from operations of $241,776 and may incur additional future losses. At September 30, 2024, the Company had total current assets of $203,058 and total current liabilities of $5,001,660, resulting in a working capital deficit of $4,798,602. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after that date that the consolidated financial statements are issued.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The Company’s existence is dependent upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that the Company’s efforts will be successful. No assurance can be given that management’s actions will result in profitable operations or the resolution of its liquidity problems. The accompanying consolidated financial statements do not include any adjustments that might result should the company be unable to continue as a going concern. &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-indent:18pt;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;In order to improve the Company’s liquidity, the Company’s management is actively pursuing additional equity financing through discussions with investment bankers and private investors. There can be no assurance that the Company will be successful in its effort to secure additional equity financing.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-indent:18pt;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
  <us-gaap:SharesOutstanding id="f117" decimals="INF" contextRef="c44" unitRef="shares">14896791.0</us-gaap:SharesOutstanding>
  <tpia:DueToRelatedParties id="f118" decimals="128" contextRef="c16" unitRef="usd">0.0</tpia:DueToRelatedParties>
  <us-gaap:StockholdersEquity id="f119" decimals="INF" contextRef="c45" unitRef="usd">6953439.0</us-gaap:StockholdersEquity>
  <us-gaap:GeneralAndAdministrativeExpense id="f120" decimals="INF" contextRef="c" unitRef="usd">1137539.0</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:StockholdersEquity id="f121" decimals="128" contextRef="c46" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="f122" decimals="128" contextRef="c47" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <tpia:ConvertibleDebtOutstanding id="f123" decimals="INF" contextRef="c48" unitRef="usd">2407.0</tpia:ConvertibleDebtOutstanding>
  <us-gaap:ShareBasedCompensation id="f124" decimals="INF" contextRef="c49" unitRef="usd">635.0</us-gaap:ShareBasedCompensation>
  <us-gaap:Depreciation id="f125" decimals="INF" contextRef="c50" unitRef="usd">498.0</us-gaap:Depreciation>
  <us-gaap:ConvertibleNotesPayable id="f126" decimals="INF" contextRef="c51" unitRef="usd">325000.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="f127" decimals="INF" contextRef="c16" unitRef="usd">-8960981.0</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:Depreciation id="f128" decimals="INF" contextRef="c52" unitRef="usd">747.0</us-gaap:Depreciation>
  <tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses id="f129" decimals="INF" contextRef="c8" unitRef="usd">38.0</tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="f130" decimals="128" contextRef="c" unitRef="usd1">0.0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:CommonStockValue id="f131" decimals="INF" contextRef="c25" unitRef="usd">5482.0</us-gaap:CommonStockValue>
  <tpia:ExchangeOfCommonStockForSeriesAPreferredStock id="f132" decimals="128" contextRef="c53" unitRef="usd">0.0</tpia:ExchangeOfCommonStockForSeriesAPreferredStock>
  <us-gaap:NetIncomeLoss id="f133" decimals="INF" contextRef="c54" unitRef="usd">-425942.0</us-gaap:NetIncomeLoss>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="f134" decimals="INF" contextRef="c25" unitRef="usd1">1.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree id="f135" decimals="INF" contextRef="c25" unitRef="usd">605839.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
  <us-gaap:SharesOutstanding id="f136" decimals="128" contextRef="c55" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <tpia:AccruedExpensesRelatedParty id="f137" decimals="INF" contextRef="c25" unitRef="usd">792000.0</tpia:AccruedExpensesRelatedParty>
  <tpia:ExchangeOfCommonStockForSeriesAPreferredStock id="f138" decimals="128" contextRef="c37" unitRef="usd">0.0</tpia:ExchangeOfCommonStockForSeriesAPreferredStock>
  <us-gaap:EarningsPerSharePolicyTextBlock id="f139" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Basic and Diluted Net Loss per Share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. The common stock equivalents not included in the computation of earnings per share because the effect was antidilutive, were related to convertible debt and totaled 1,819,217 and 1,286,248 shares for the nine months ended September 30, 2024 and 2023, respectively, and the outstanding warrants that totaled 333,333 and 1,211,091 shares for the nine months ended September 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;
</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentTextBlock id="f140" contextRef="c">&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#FFFFFF;width:80%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt;Property and Equipment, Net Categories&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:2%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Equipment&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;3 Years&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:StockholdersEquity id="f141" decimals="INF" contextRef="c56" unitRef="usd">-8670020.0</us-gaap:StockholdersEquity>
  <us-gaap:ConvertibleNotesPayable id="f142" decimals="INF" contextRef="c39" unitRef="usd">55000.0</us-gaap:ConvertibleNotesPayable>
  <tpia:ConsultingFee id="f143" decimals="INF" contextRef="c" unitRef="usd">288000.0</tpia:ConsultingFee>
  <tpia:ConvertibleDebtOutstanding id="f144" decimals="INF" contextRef="c16" unitRef="usd">1339714.0</tpia:ConvertibleDebtOutstanding>
  <dei:CityAreaCode id="f145" contextRef="c">954</dei:CityAreaCode>
  <us-gaap:SharesOutstanding id="f146" decimals="128" contextRef="c57" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="f147" decimals="INF" contextRef="c58" unitRef="usd">316985.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <tpia:ConvertibleDebtInterest id="f148" decimals="INF" contextRef="c32" unitRef="usd">225792.0</tpia:ConvertibleDebtInterest>
  <us-gaap:SharesOutstanding id="f149" decimals="128" contextRef="c59" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding id="f150" decimals="128" contextRef="c60" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <us-gaap:ConvertibleNotesPayable id="f151" decimals="INF" contextRef="c43" unitRef="usd">165000.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:NetIncomeLoss id="f152" decimals="128" contextRef="c38" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f153" decimals="INF" contextRef="c4" unitRef="usd1">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:InterestPaid id="f154" decimals="128" contextRef="c" unitRef="usd">0.0</us-gaap:InterestPaid>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="f155" decimals="INF" contextRef="c16" unitRef="usd">60219.0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod id="f156" decimals="INF" contextRef="c17" unitRef="shares">333333.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <tpia:AverageNumberOfCommonShareOutstandingBasicAndDiluted id="f157" decimals="INF" contextRef="c17" unitRef="shares">14879756.0</tpia:AverageNumberOfCommonShareOutstandingBasicAndDiluted>
  <us-gaap:StockholdersEquity id="f158" decimals="INF" contextRef="c61" unitRef="usd">14897.0</us-gaap:StockholdersEquity>
  <us-gaap:ProceedsFromRelatedPartyDebt id="f159" decimals="128" contextRef="c17" unitRef="usd">0.0</us-gaap:ProceedsFromRelatedPartyDebt>
  <us-gaap:AssetsCurrent id="f160" decimals="INF" contextRef="c25" unitRef="usd">203058.0</us-gaap:AssetsCurrent>
  <tpia:ExchangeOfCommonStockForSeriesAPreferredStock id="f161" decimals="128" contextRef="c62" unitRef="usd">0.0</tpia:ExchangeOfCommonStockForSeriesAPreferredStock>
  <tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses id="f162" decimals="INF" contextRef="c" unitRef="usd">26250.0</tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
  <us-gaap:ShareBasedCompensation id="f163" decimals="INF" contextRef="c17" unitRef="usd">635.0</us-gaap:ShareBasedCompensation>
  <us-gaap:SharesOutstanding id="f164" decimals="128" contextRef="c63" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <us-gaap:InterestExpense id="f165" decimals="INF" contextRef="c9" unitRef="usd">143279.0</us-gaap:InterestExpense>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy id="f166" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The Company accounts for financial instruments in accordance with ASC 820, &lt;i&gt;Fair Value Measurements and Disclosures.&lt;/i&gt;  ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below:&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;There were no changes in the fair value hierarchy leveling during the nine months ended September 30, 2024 and 2023.&lt;/p&gt;
</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <dei:LocalPhoneNumber id="f167" contextRef="c">233-3511</dei:LocalPhoneNumber>
  <us-gaap:StockholdersEquity id="f168" decimals="INF" contextRef="c64" unitRef="usd">-8082638.0</us-gaap:StockholdersEquity>
  <us-gaap:OperatingExpenses id="f169" decimals="INF" contextRef="c9" unitRef="usd">165421.0</us-gaap:OperatingExpenses>
  <us-gaap:StockholdersEquity id="f170" decimals="INF" contextRef="c44" unitRef="usd">14897.0</us-gaap:StockholdersEquity>
  <us-gaap:PreferredStockSharesOutstanding id="f171" decimals="INF" contextRef="c22" unitRef="shares">0.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:SharesOutstanding id="f172" decimals="INF" contextRef="c65" unitRef="shares">14858357.0</us-gaap:SharesOutstanding>
  <us-gaap:NetIncomeLoss id="f173" decimals="128" contextRef="c49" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:Assets id="f174" decimals="INF" contextRef="c25" unitRef="usd">1642839.0</us-gaap:Assets>
  <us-gaap:StockholdersEquity id="f175" decimals="INF" contextRef="c11" unitRef="usd">-891348.0</us-gaap:StockholdersEquity>
  <dei:DocumentPeriodEndDate id="f176" contextRef="c">2024-09-30</dei:DocumentPeriodEndDate>
  <dei:EntityCommonStockSharesOutstanding id="f177" decimals="INF" contextRef="c66" unitRef="shares">5990903.0</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:LiabilitiesAndStockholdersEquity id="f178" decimals="INF" contextRef="c25" unitRef="usd">1642839.0</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:SharesOutstanding id="f179" decimals="128" contextRef="c41" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding id="f180" decimals="128" contextRef="c67" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <us-gaap:ShareBasedCompensation id="f181" decimals="128" contextRef="c68" unitRef="usd">0.0</us-gaap:ShareBasedCompensation>
  <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet id="f182" decimals="INF" contextRef="c17" unitRef="usd">-76197.0</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
  <us-gaap:StockholdersEquity id="f183" decimals="128" contextRef="c47" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <us-gaap:NetIncomeLoss id="f184" decimals="128" contextRef="c69" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <tpia:ConvertibleDebtInterest id="f185" decimals="INF" contextRef="c39" unitRef="usd">12950.0</tpia:ConvertibleDebtInterest>
  <tpia:IncreaseInPrepaidExpenses id="f186" decimals="INF" contextRef="c" unitRef="usd">-700.0</tpia:IncreaseInPrepaidExpenses>
  <us-gaap:GeneralAndAdministrativeExpense id="f187" decimals="INF" contextRef="c17" unitRef="usd">427785.0</us-gaap:GeneralAndAdministrativeExpense>
  <tpia:ConvertibleDebtOutstanding id="f188" decimals="INF" contextRef="c70" unitRef="usd">626884.0</tpia:ConvertibleDebtOutstanding>
  <us-gaap:NetIncomeLoss id="f189" decimals="128" contextRef="c71" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:LiabilitiesCurrent id="f190" decimals="INF" contextRef="c25" unitRef="usd">5001660.0</us-gaap:LiabilitiesCurrent>
  <tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses id="f191" decimals="INF" contextRef="c49" unitRef="usd">43712.0</tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
  <tpia:WorkingCapital id="f192" decimals="INF" contextRef="c25" unitRef="usd">4798602.0</tpia:WorkingCapital>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect id="f193" decimals="INF" contextRef="c" unitRef="usd">-76776.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
  <tpia:ConvertibleDebtInterest id="f194" decimals="INF" contextRef="c43" unitRef="usd">1930.0</tpia:ConvertibleDebtInterest>
  <us-gaap:Liabilities id="f195" decimals="INF" contextRef="c25" unitRef="usd">5001660.0</us-gaap:Liabilities>
  <tpia:CommonStockIssuedOnCashlessExerciseOfWarrantShares id="f196" decimals="128" contextRef="c" unitRef="shares">0.0</tpia:CommonStockIssuedOnCashlessExerciseOfWarrantShares>
  <us-gaap:Depreciation id="f197" decimals="INF" contextRef="c17" unitRef="usd">747.0</us-gaap:Depreciation>
  <us-gaap:ConvertibleDebtTableTextBlock id="f198" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="5" style="width:38.84%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;September 30, 2024&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="5" style="width:36.76%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Maturity Date&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Total Outstanding***&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.3%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Principal&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.68%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Total Outstanding***&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.22%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Principal&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:7.68%;border-bottom:1pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender A&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;8/27/2023&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;725,792&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; $&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;500,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;225,792&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; $&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;626,884&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; $&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;500,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;126,884&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender B&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;9/27/2023&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;78,671&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;55,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;23,671&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;67,950&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;55,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;12,950&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender C&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;10/27/2023&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;309,089&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;220,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;89,089&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;266,968&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;220,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;46,968&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender D&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;10/21/2023&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;2,407&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;2,407&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;2,407&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;2,407&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:8pt"&gt;&lt;b&gt;&lt;i&gt;Lender E&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;1/21/2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;431,698&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;325,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;106,698&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;375,504&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;325,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;50,504&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;b&gt;&lt;i&gt;Lender F&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:center"&gt;1/30/2025&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;166,930&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;165,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;1,930&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:7.8%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0"&gt;&lt;span style="font-size:8pt"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt; $&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,714,587&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt; $&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.3%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,265,000&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:9.68%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;449,587&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt; $&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:13.9%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,339,714&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt; $&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:10.22%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;1,100,000&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:7.68%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:right"&gt;&lt;b&gt;239,714&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.3%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:13.9%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:10.22%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:7.68%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:7.8%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.46%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:9.18%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.48%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="11" style="width:78.08%" valign="bottom"&gt;&lt;p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;&lt;b&gt;&lt;i&gt;*** - Total Outstanding = Principal + Interest as of September 30, 2024 and December 31, 2023&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ConvertibleDebtTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="f199" decimals="INF" contextRef="c58" unitRef="shares">1211091.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ConvertibleNotesPayable id="f200" decimals="INF" contextRef="c16" unitRef="usd">1100000.0</us-gaap:ConvertibleNotesPayable>
  <tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses id="f201" decimals="INF" contextRef="c7" unitRef="usd">26250.0</tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
  <us-gaap:OperatingIncomeLoss id="f202" decimals="INF" contextRef="c17" unitRef="usd">-427785.0</us-gaap:OperatingIncomeLoss>
  <us-gaap:CommonStockValue id="f203" decimals="INF" contextRef="c16" unitRef="usd">14897.0</us-gaap:CommonStockValue>
  <us-gaap:DebtInstrumentMaturityDate id="f204" contextRef="c72">2023-10-21</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:StockholdersEquity id="f205" decimals="128" contextRef="c60" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="f206" decimals="INF" contextRef="c73" unitRef="usd">5482.0</us-gaap:StockholdersEquity>
  <tpia:WarrantsIssuedShares id="f207" decimals="INF" contextRef="c74" unitRef="shares">1922.0</tpia:WarrantsIssuedShares>
  <tpia:AccruedExpensesRelatedParty id="f208" decimals="INF" contextRef="c16" unitRef="usd">576000.0</tpia:AccruedExpensesRelatedParty>
  <us-gaap:NetIncomeLoss id="f209" decimals="INF" contextRef="c75" unitRef="usd">-460144.0</us-gaap:NetIncomeLoss>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="f210" decimals="INF" contextRef="c25" unitRef="usd">495073.0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <tpia:WarrantsIssuedValue id="f211" decimals="INF" contextRef="c74" unitRef="usd">635.0</tpia:WarrantsIssuedValue>
  <us-gaap:SharesOutstanding id="f212" decimals="INF" contextRef="c76" unitRef="shares">14858357.0</us-gaap:SharesOutstanding>
  <tpia:ConvertibleDebtInterest id="f213" decimals="INF" contextRef="c48" unitRef="usd">2407.0</tpia:ConvertibleDebtInterest>
  <us-gaap:StockholdersEquity id="f214" decimals="128" contextRef="c63" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <tpia:UnamortizedDebtDiscount id="f215" decimals="INF" contextRef="c25" unitRef="usd">0.0</tpia:UnamortizedDebtDiscount>
  <us-gaap:NetIncomeLoss id="f216" decimals="128" contextRef="c8" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:ConvertibleNotesPayable id="f217" decimals="INF" contextRef="c70" unitRef="usd">500000.0</us-gaap:ConvertibleNotesPayable>
  <tpia:AverageNumberOfCommonShareOutstandingBasicAndDiluted id="f218" decimals="INF" contextRef="c7" unitRef="shares">8103952.0</tpia:AverageNumberOfCommonShareOutstandingBasicAndDiluted>
  <us-gaap:NetIncomeLoss id="f219" decimals="INF" contextRef="c77" unitRef="usd">-425942.0</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="f220" decimals="INF" contextRef="c78" unitRef="usd">6917774.0</us-gaap:StockholdersEquity>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="f221" decimals="INF" contextRef="c79" unitRef="shares">1819217.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <tpia:ConvertibleDebtOutstanding id="f222" decimals="128" contextRef="c80" unitRef="usd">0.0</tpia:ConvertibleDebtOutstanding>
  <dei:EntityTaxIdentificationNumber id="f223" contextRef="c">87-0645794</dei:EntityTaxIdentificationNumber>
  <us-gaap:PreferredStockSharesAuthorized id="f224" decimals="INF" contextRef="c4" unitRef="shares">1.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:StockholdersEquity id="f225" decimals="128" contextRef="c41" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="f226" decimals="128" contextRef="c67" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <us-gaap:InterestPaid id="f227" decimals="128" contextRef="c17" unitRef="usd">0.0</us-gaap:InterestPaid>
  <us-gaap:IncomeTaxExpenseBenefit id="f228" decimals="128" contextRef="c" unitRef="usd">0.0</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:ShareBasedCompensation id="f229" decimals="INF" contextRef="c81" unitRef="usd">635.0</us-gaap:ShareBasedCompensation>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="f230" decimals="INF" contextRef="c82" unitRef="shares">1286248.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AssetsCurrent id="f231" decimals="INF" contextRef="c16" unitRef="usd">279134.0</us-gaap:AssetsCurrent>
  <us-gaap:PreferredStockSharesAuthorized id="f232" decimals="INF" contextRef="c25" unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="f233" decimals="INF" contextRef="c83" unitRef="shares">333333.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:Cash id="f234" decimals="INF" contextRef="c25" unitRef="usd">202358.0</us-gaap:Cash>
  <us-gaap:NetIncomeLoss id="f235" decimals="128" contextRef="c84" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <tpia:ExchangeOfCommonStockForSeriesAPreferredStock id="f236" decimals="INF" contextRef="c" unitRef="usd">9794.0</tpia:ExchangeOfCommonStockForSeriesAPreferredStock>
  <us-gaap:ShareBasedCompensation id="f237" decimals="128" contextRef="c85" unitRef="usd">0.0</us-gaap:ShareBasedCompensation>
  <tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses id="f238" decimals="128" contextRef="c68" unitRef="usd">0.0</tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="f239" decimals="INF" contextRef="c86" unitRef="shares">1211091.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:StockholdersEquity id="f240" decimals="INF" contextRef="c25" unitRef="usd">-3358821.0</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="f241" decimals="INF" contextRef="c87" unitRef="shares">14896791.0</us-gaap:SharesOutstanding>
  <tpia:ConvertibleDebtInterest id="f242" decimals="INF" contextRef="c16" unitRef="usd">239714.0</tpia:ConvertibleDebtInterest>
  <us-gaap:LiabilitiesAndStockholdersEquity id="f243" decimals="INF" contextRef="c16" unitRef="usd">2219413.0</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:GeneralAndAdministrativeExpense id="f244" decimals="INF" contextRef="c7" unitRef="usd">385257.0</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:PriorPeriodReclassificationAdjustmentDescription id="f245" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Prior period reclassifications&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;We have reclassified certain amounts in prior periods to conform with current presentation. Increase in accrued interest in the amount of $76,197 which was reported within the increase in accounts payable and accrued expenses at September 30, 2023, has been reclassified on the statement of cash flows. Common stock issued to settle accounts payable and accrued expenses of $43,750 which was reported within stock based compensation at September 30, 2023, has been reclassified on the statement of cash flows.&lt;/span&gt;&lt;/p&gt;
</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
  <tpia:ShareholderLoan id="f246" decimals="INF" contextRef="c16" unitRef="usd">2000000.0</tpia:ShareholderLoan>
  <us-gaap:StockholdersEquity id="f247" decimals="INF" contextRef="c88" unitRef="usd">-9857598.0</us-gaap:StockholdersEquity>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="f248" decimals="128" contextRef="c" unitRef="usd">0.0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue id="f249" decimals="INF" contextRef="c25" unitRef="usd">0.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <tpia:IncreaseInPrepaidExpenses id="f250" decimals="128" contextRef="c17" unitRef="usd">0.0</tpia:IncreaseInPrepaidExpenses>
  <us-gaap:PropertyPlantAndEquipmentNet id="f251" decimals="128" contextRef="c25" unitRef="usd">0.0</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:SharesOutstanding id="f252" decimals="INF" contextRef="c4" unitRef="shares">1.0</us-gaap:SharesOutstanding>
  <tpia:ExchangeOfCommonStockForSeriesAPreferredStock id="f253" decimals="128" contextRef="c17" unitRef="usd">0.0</tpia:ExchangeOfCommonStockForSeriesAPreferredStock>
  <tpia:ConvertibleDebtInterest id="f254" decimals="INF" contextRef="c70" unitRef="usd">126884.0</tpia:ConvertibleDebtInterest>
  <tpia:ConvertibleDebtOutstanding id="f255" decimals="INF" contextRef="c89" unitRef="usd">2407.0</tpia:ConvertibleDebtOutstanding>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="f256" decimals="INF" contextRef="c16" unitRef="shares">666666.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect id="f257" decimals="INF" contextRef="c17" unitRef="usd">-68914.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
  <us-gaap:NonoperatingIncomeExpense id="f258" decimals="INF" contextRef="c" unitRef="usd">-219222.0</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:ConvertibleNotesPayable id="f259" decimals="128" contextRef="c80" unitRef="usd">0.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:AmortizationOfDebtDiscountPremium id="f260" decimals="INF" contextRef="c" unitRef="usd">9349.0</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:SharesOutstanding id="f261" decimals="INF" contextRef="c90" unitRef="shares">14896791.0</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity id="f262" decimals="INF" contextRef="c76" unitRef="usd">14857.0</us-gaap:StockholdersEquity>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy id="f263" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Stock Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;We follow ASC 718, &lt;i&gt;Compensation–Stock Compensation,&lt;/i&gt; which prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Share-based payments to employees and non-employees, including grants of stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).&lt;/p&gt;
</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:SharesOutstanding id="f264" decimals="128" contextRef="c91" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <us-gaap:NetIncomeLoss id="f265" decimals="128" contextRef="c92" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="f266" decimals="128" contextRef="c93" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:Depreciation id="f267" decimals="INF" contextRef="c" unitRef="usd">498.0</us-gaap:Depreciation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="f268" decimals="INF" contextRef="c58" unitRef="usd1">0.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:PreferredStockSharesAuthorized id="f269" decimals="INF" contextRef="c16" unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:StockholdersEquity id="f270" decimals="INF" contextRef="c94" unitRef="usd">-9386923.0</us-gaap:StockholdersEquity>
  <tpia:ConvertibleDebtInterest id="f271" decimals="INF" contextRef="c89" unitRef="usd">2407.0</tpia:ConvertibleDebtInterest>
  <tpia:IncreaseDecreaseInAccruedExpensesRelatedParty id="f272" decimals="INF" contextRef="c" unitRef="usd">216000.0</tpia:IncreaseDecreaseInAccruedExpensesRelatedParty>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="f273" decimals="INF" contextRef="c" unitRef="usd">165000.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <tpia:CommonStockIssuedOnCashlessExerciseOfWarrantShares id="f274" decimals="128" contextRef="c17" unitRef="shares">0.0</tpia:CommonStockIssuedOnCashlessExerciseOfWarrantShares>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="f275" decimals="INF" contextRef="c16" unitRef="usd">341358.0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:SharesOutstanding id="f276" decimals="128" contextRef="c22" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding id="f277" decimals="128" contextRef="c20" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <tpia:ConvertibleDebtOutstanding id="f278" decimals="INF" contextRef="c51" unitRef="usd">431698.0</tpia:ConvertibleDebtOutstanding>
  <us-gaap:DebtInstrumentMaturityDate id="f279" contextRef="c95">2023-10-27</us-gaap:DebtInstrumentMaturityDate>
  <tpia:AverageNumberOfCommonShareOutstandingBasicAndDiluted id="f280" decimals="INF" contextRef="c9" unitRef="shares">14896791.0</tpia:AverageNumberOfCommonShareOutstandingBasicAndDiluted>
  <tpia:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm id="f281" decimals="INF" contextRef="c17" unitRef="pure">0.38</tpia:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm>
  <us-gaap:NetIncomeLoss id="f282" decimals="128" contextRef="c27" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:SignificantAccountingPoliciesTextBlock id="f283" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;i&gt; &lt;/i&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin-top:0pt;margin-bottom:8pt;text-align:justify"&gt;The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of September 30, 2024, and the results of its operations and its cash flows for the nine months ended September 30, 2024 and 2023. The balance sheet as of December 31, 2023 is derived from the Company’s audited financial statements. The results of operations for the nine months ended September 30, 2024 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2024.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, MYC and NPD. All inter-company accounts and transactions have been eliminated in consolidation.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The preparation of financial statements in conformity with U.S GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Our financial statements include, when applicable, disclosures of estimates, assumptions, uncertainties, and markets that could affect our financial statements and future operations.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Cash&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The Company considers all highly liquid investments with original maturities at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents include bank demand deposits, marketable securities with maturities of three months or less at purchase, and money market funds that invest primarily in certificates of deposits, commercial paper and U.S. government and U.S. government agency obligations. Cash equivalents are reported at fair value. The Company maintains its cash balances with a bank whose balance is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. The Company monitors the cash balances held in its bank accounts, and as of September 30, 2024, and December 31, 2023, did not have any concerns regarding cash balances which exceeded the insured amounts.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Property and Equipment, Net&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Property and equipment are stated at cost. For financial reporting, we provide for depreciation using the straight-line method at rates based upon the estimated useful lives of the various assets. Depreciation expense was $498 and $747 for the nine months ended September 30, 2024, and 2023, respectively. The Company computes depreciation utilizing estimated useful lives, as stated below:&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#FFFFFF;width:80%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt;Property and Equipment, Net Categories&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:2%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Equipment&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;3 Years&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Management assesses property and equipment for impairment whenever there is an indicator of impairment. Impairment losses are evaluated if the estimated undiscounted cash flows from using the assets are less than carrying value. A loss is recognized when the carrying value of an asset exceeds its fair value. Management assessed and concluded that no impairment write-down would be necessary for the Company’s property and equipment as of September 30, 2024 and December 31, 2023.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Finite Long-lived Intangible Assets, Net&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;Finite long-lived intangible assets are recorded at their estimated fair value at the date of acquisition. Finite long-lived intangible assets are amortized on a straight-line basis over their estimated useful lives. Management annually evaluates the estimated remaining useful lives of the finite intangible assets to determine whether events or changes in circumstances warrant a revision to the remaining period of amortization. The Company acquired the finite intangible asset, intellectual property, as part of the Philon Labs asset acquisition during the year ended December 31, 2023 (Note 4 – Intangible Assets, Net).&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;Finite long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be fully recoverable. An impairment loss is recognized if the sum of the expected long-term undiscounted cash flows the asset is expected to generate is less than its carrying amount. Any write-downs are treated as permanent reductions in the carrying amount of the respective asset. Management assessed and concluded that no impairment write-down would be necessary for finite long-lived intangible assets as of September 30, 2024, and December 31, 2023.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;The Company amortizes these intangible assets on a straight-line basis over their estimated useful lives, as stated below:&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#FFFFFF;width:80%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt;Intangible Assets, Net Categories&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:2%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Intellectual property&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;3 Years&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The Company accounts for financial instruments in accordance with ASC 820, &lt;i&gt;Fair Value Measurements and Disclosures.&lt;/i&gt;  ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below:&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;There were no changes in the fair value hierarchy leveling during the nine months ended September 30, 2024 and 2023.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The Company provides for income taxes using the asset and liability approach. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of September 30, 2024 and December 31, 2023, the Company had a full valuation allowance against its deferred tax assets.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;We adopted ASC 740-10-25, &lt;i&gt;Income Taxes—Recognition&lt;/i&gt;, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC 740-10-25, we may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. ASC 740-10-25 also provides guidance on derecognition, classification, interest and penalties on income taxes, and accounting in interim periods and requires increased disclosures. We had no material adjustments to our liabilities for unrecognized income tax benefits according to the provisions of ASC 740-10-25.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Stock Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;We follow ASC 718, &lt;i&gt;Compensation–Stock Compensation,&lt;/i&gt; which prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Share-based payments to employees and non-employees, including grants of stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Basic and Diluted Net Loss per Share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. The common stock equivalents not included in the computation of earnings per share because the effect was antidilutive, were related to convertible debt and totaled 1,819,217 and 1,286,248 shares for the nine months ended September 30, 2024 and 2023, respectively, and the outstanding warrants that totaled 333,333 and 1,211,091 shares for the nine months ended September 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Prior period reclassifications&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;We have reclassified certain amounts in prior periods to conform with current presentation. Increase in accrued interest in the amount of $76,197 which was reported within the increase in accounts payable and accrued expenses at September 30, 2023, has been reclassified on the statement of cash flows. Common stock issued to settle accounts payable and accrued expenses of $43,750 which was reported within stock based compensation at September 30, 2023, has been reclassified on the statement of cash flows.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Recently Issued Accounting Standards &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying consolidated financial statements, other than those disclosed below.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;In December 2023, the FASB issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740) – Improvements to Income Tax Disclosures”. ASU 2023-09 requires that an entity, on an annual basis, disclose additional income tax information, primarily related to the rate reconciliation and income taxes paid. The amendment in the ASU is intended to enhance the transparency and decision usefulness of income tax disclosures. The ASU’s amendments are effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the impact ASU 2023-09 will have on its financial statements.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Recently Adopted Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40)” (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The Company adopted ASU 2020-06 effective January 1, 2024 and the adoption of ASU 2020-06 did not have a material impact on the Company’s financial statements.&lt;/p&gt;
</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:IncomeTaxExpenseBenefit id="f284" decimals="128" contextRef="c17" unitRef="usd">0.0</us-gaap:IncomeTaxExpenseBenefit>
  <tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses id="f285" decimals="INF" contextRef="c81" unitRef="usd">43750.0</tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
  <tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses id="f286" decimals="INF" contextRef="c17" unitRef="usd">43750.0</tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
  <us-gaap:ConvertibleNotesPayable id="f287" decimals="128" contextRef="c89" unitRef="usd">0.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:StockholdersEquity id="f288" decimals="INF" contextRef="c87" unitRef="usd">14897.0</us-gaap:StockholdersEquity>
  <us-gaap:PreferredStockSharesAuthorized id="f289" decimals="INF" contextRef="c22" unitRef="shares">0.0</us-gaap:PreferredStockSharesAuthorized>
  <tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses id="f290" decimals="128" contextRef="c85" unitRef="usd">0.0</tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
  <tpia:ConvertibleDebtInterest id="f291" decimals="128" contextRef="c80" unitRef="usd">0.0</tpia:ConvertibleDebtInterest>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="f292" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;NOTE 9 – COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On November 17, 2021, the Company entered into an Executive Consulting Agreement (the “Agreement”) with Benjamin Kaplan whereby Mr. Kaplan was appointed as CEO of the Company (see Note 5 – Related Party Transactions).&lt;/p&gt;
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="f293" decimals="INF" contextRef="c16" unitRef="usd">279134.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:Cash id="f294" decimals="INF" contextRef="c16" unitRef="usd">279134.0</us-gaap:Cash>
  <us-gaap:AdditionalPaidInCapital id="f295" decimals="INF" contextRef="c25" unitRef="usd">6953439.0</us-gaap:AdditionalPaidInCapital>
  <us-gaap:GeneralAndAdministrativeExpense id="f296" decimals="INF" contextRef="c9" unitRef="usd">165421.0</us-gaap:GeneralAndAdministrativeExpense>
  <tpia:ConvertibleDebtInterest id="f297" decimals="INF" contextRef="c51" unitRef="usd">106698.0</tpia:ConvertibleDebtInterest>
  <us-gaap:ConvertibleNotesPayableCurrent id="f298" decimals="INF" contextRef="c25" unitRef="usd">1100000.0</us-gaap:ConvertibleNotesPayableCurrent>
  <us-gaap:StockholdersEquity id="f299" decimals="INF" contextRef="c16" unitRef="usd">-2028310.0</us-gaap:StockholdersEquity>
  <us-gaap:Assets id="f300" decimals="INF" contextRef="c16" unitRef="usd">2219413.0</us-gaap:Assets>
  <us-gaap:NetIncomeLoss id="f301" decimals="INF" contextRef="c" unitRef="usd">-1356761.0</us-gaap:NetIncomeLoss>
  <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock id="f302" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;NOTE 8 - STOCK BASED COMPENSATION&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On May 29, 2024, the Company signed a consulting agreement with a consultant (the “May Consulting Agreement”). The consultant agreed to provide services related to the Company’s status as a publicly traded company. In exchange the consultant is to receive 120,000 shares of the Company’s common stock at commencement of the agreement, and an additional payment of 5,000 shares of common stock each month of the agreement. The agreement is effective from May 29, 2024 through September 22, 2024. During the three and nine months ended September 30, 2024, the Company incurred $402 and $7,182, respectively, of stock-based compensation related to the May Consulting Agreement. As of September 30, 2024 the Company had accrued $7,182 of stock-based compensation related to the May Consulting Agreement as a component of Accounts Payable and Accrued Expenses.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;During 2022, the Company entered into a consulting agreement whereby the consultant agreed to act as a medical advisor to the Company for certain services. In exchange, the Company agreed to pay annual consideration of $35,000, payable in shares of common stock. The shares of common stock to be issued are to be determined using the volatility weighted average price of the common stock for the twenty days prior to the end of the quarter in which they were earned. As of December 31, 2023 and September 30, 2024, the Company had $35,000 and $35,000, respectively, recorded as component of accrued expenses on the Condensed consolidated Balance Sheet. During the year ended December 31, 2023, the Company issued 38,434 shares of common stock to settle $43,750 of accrued expenses related to the consulting agreement. On September 23, 2024, the Company issued 378,582 shares of common stock to settle $26,250 of accrued expenses related to the consulting agreement (Note 7 – Stockholders’ Equity).&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Effective July 15, 2024, the Company adopted the “Mycotopia Therapies Inc. 2024 Equity Incentive Plan” (the “2024 Plan”). The 2024 Plan is effective through July 14, 2034, and limits the number of shares that may be issued pursuant to the 2024 Plan to 50,000,000 shares of common stock. As of September 30, 2024, there have not been any stock based compensation issuances under the 2024 Plan.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Warrants Issued&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The following table reflects a summary of Common Stock warrants outstanding and warrant activity during the nine months ended September 30, 2024, and 2023:&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:9.94%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Underlying&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:20.24%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:27.56%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Weighted Average Term (Years)&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Warrants outstanding at January 1, 2023&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1,542,502&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.65&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1.29&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Granted&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1,922&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.01&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.38&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Exercised&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Forfeited/Expired&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;(333,333&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;1.50&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Warrants outstanding at September 30, 2023&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1,211,091&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.42&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.15&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Warrants outstanding at January 1, 2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;666,666&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1.50&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.80&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Granted&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Exercised&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Forfeited/Expired &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;(333,333&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;)&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1.50&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:36.4%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.1%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:8.82%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:16.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:24.1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:1.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:36.4%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Warrants outstanding and exercisable at September 30, 2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.88%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.1%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:8.82%;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;333,333&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.08%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.52%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.62%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$ &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:16.62%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1.50&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:3.46%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:24.1%" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;0.19&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:0.78%;padding-top:0.75pt;padding-left:0.75pt;padding-bottom:2.5pt;padding-right:0.75pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The intrinsic value of warrants outstanding as of September 30, 2024 was $0.&lt;/p&gt;
</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
  <us-gaap:StockholdersEquity id="f303" decimals="INF" contextRef="c90" unitRef="usd">14895.0</us-gaap:StockholdersEquity>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="f304" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Recently Issued Accounting Standards &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying consolidated financial statements, other than those disclosed below.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;In December 2023, the FASB issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740) – Improvements to Income Tax Disclosures”. ASU 2023-09 requires that an entity, on an annual basis, disclose additional income tax information, primarily related to the rate reconciliation and income taxes paid. The amendment in the ASU is intended to enhance the transparency and decision usefulness of income tax disclosures. The ASU’s amendments are effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the impact ASU 2023-09 will have on its financial statements.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Recently Adopted Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40)” (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The Company adopted ASU 2020-06 effective January 1, 2024 and the adoption of ASU 2020-06 did not have a material impact on the Company’s financial statements.&lt;/p&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:StockholdersEquity id="f305" decimals="INF" contextRef="c96" unitRef="usd">6873429.0</us-gaap:StockholdersEquity>
  <us-gaap:PropertyPlantAndEquipmentNet id="f306" decimals="INF" contextRef="c16" unitRef="usd">498.0</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:NonoperatingIncomeExpense id="f307" decimals="INF" contextRef="c17" unitRef="usd">-462601.0</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:IntangibleAssetsFiniteLivedPolicy id="f308" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Finite Long-lived Intangible Assets, Net&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;Finite long-lived intangible assets are recorded at their estimated fair value at the date of acquisition. Finite long-lived intangible assets are amortized on a straight-line basis over their estimated useful lives. Management annually evaluates the estimated remaining useful lives of the finite intangible assets to determine whether events or changes in circumstances warrant a revision to the remaining period of amortization. The Company acquired the finite intangible asset, intellectual property, as part of the Philon Labs asset acquisition during the year ended December 31, 2023 (Note 4 – Intangible Assets, Net).&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;Finite long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be fully recoverable. An impairment loss is recognized if the sum of the expected long-term undiscounted cash flows the asset is expected to generate is less than its carrying amount. Any write-downs are treated as permanent reductions in the carrying amount of the respective asset. Management assessed and concluded that no impairment write-down would be necessary for finite long-lived intangible assets as of September 30, 2024, and December 31, 2023.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;The Company amortizes these intangible assets on a straight-line basis over their estimated useful lives, as stated below:&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="background-color:#FFFFFF;width:80%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt;Intangible Assets, Net Categories&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:2%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#FFFFFF;width:18%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Intellectual property&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;3 Years&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:IntangibleAssetsFiniteLivedPolicy>
  <us-gaap:StockholdersEquity id="f309" decimals="128" contextRef="c91" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <us-gaap:AdjustmentForAmortization id="f310" decimals="INF" contextRef="c" unitRef="usd">500000.0</us-gaap:AdjustmentForAmortization>
  <us-gaap:BasisOfAccounting id="f311" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin-top:0pt;margin-bottom:8pt;text-align:justify"&gt;The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of September 30, 2024, and the results of its operations and its cash flows for the nine months ended September 30, 2024 and 2023. The balance sheet as of December 31, 2023 is derived from the Company’s audited financial statements. The results of operations for the nine months ended September 30, 2024 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2024.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, MYC and NPD. All inter-company accounts and transactions have been eliminated in consolidation.&lt;/p&gt;
</us-gaap:BasisOfAccounting>
  <us-gaap:StockholdersEquity id="f312" decimals="INF" contextRef="c97" unitRef="usd">-10317742.0</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="f313" decimals="INF" contextRef="c73" unitRef="shares">5481619.0</us-gaap:SharesOutstanding>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths id="f314" decimals="INF" contextRef="c25" unitRef="usd">167883.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod id="f315" decimals="INF" contextRef="c17" unitRef="shares">1922.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:StockholdersEquity id="f316" decimals="INF" contextRef="c98" unitRef="usd">-2454252.0</us-gaap:StockholdersEquity>
  <us-gaap:NetIncomeLoss id="f317" decimals="INF" contextRef="c81" unitRef="usd">-278682.0</us-gaap:NetIncomeLoss>
  <us-gaap:IncomeTaxesPaid id="f318" decimals="128" contextRef="c" unitRef="usd">0.0</us-gaap:IncomeTaxesPaid>
  <us-gaap:AmortizationOfDebtDiscountPremium id="f319" decimals="INF" contextRef="c17" unitRef="usd">386403.0</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:StockholdersEquity id="f320" decimals="128" contextRef="c22" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="f321" decimals="INF" contextRef="c16" unitRef="usd1">1.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:OperatingIncomeLoss id="f322" decimals="INF" contextRef="c7" unitRef="usd">-385257.0</us-gaap:OperatingIncomeLoss>
  <us-gaap:StockholdersEquity id="f323" decimals="128" contextRef="c59" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <tpia:ConvertibleDebtOutstanding id="f324" decimals="INF" contextRef="c99" unitRef="usd">309089.0</tpia:ConvertibleDebtOutstanding>
  <us-gaap:SharesOutstanding id="f325" decimals="128" contextRef="c46" unitRef="shares">0.0</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity id="f326" decimals="INF" contextRef="c58" unitRef="usd">-1737349.0</us-gaap:StockholdersEquity>
  <us-gaap:NetIncomeLoss id="f327" decimals="INF" contextRef="c40" unitRef="usd">-470675.0</us-gaap:NetIncomeLoss>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="f328" decimals="INF" contextRef="c11" unitRef="usd">385899.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:NetIncomeLoss id="f329" decimals="128" contextRef="c100" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="f330" decimals="INF" contextRef="c" unitRef="usd">-241776.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:ShareBasedCompensation id="f331" decimals="128" contextRef="c26" unitRef="usd">0.0</us-gaap:ShareBasedCompensation>
  <tpia:ConvertibleDebtOutstanding id="f332" decimals="INF" contextRef="c101" unitRef="usd">375504.0</tpia:ConvertibleDebtOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="f333" decimals="INF" contextRef="c" unitRef="usd">-1356761.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:StockholdersEquity id="f334" decimals="INF" contextRef="c102" unitRef="usd">6917774.0</us-gaap:StockholdersEquity>
  <us-gaap:SubsequentEventsTextBlock id="f335" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;NOTE 10 – SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The Company has evaluated subsequent events from September 30, 2024 through the issuance date of these financial statements, and there are no events requiring disclosure other than those described below:&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt;Subsequent to September 30, 2024, the Company issued 200,000 shares of Series B Preferred Stock to the seller as satisfaction of the consideration owed to Philon Labs for the acquisition of intangible assets (Note 4 – Assets Acquisition).&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On November 6, 2024, the Company issued 254,642 shares of common stock to a consultant as consideration for services rendered for the Company.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On November 6, 2024, the Company issued 254,642 shares of common stock to a consultant as consideration for services agreed to under a professional services agreement.&lt;/p&gt;
</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="f336" decimals="128" contextRef="c17" unitRef="usd">0.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:IncomeTaxExpenseBenefit id="f337" decimals="128" contextRef="c7" unitRef="usd">0.0</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="f338" decimals="INF" contextRef="c" unitRef="usd">179965.0</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock id="f339" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;NOTE 5 – RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Notes Payable – Related Parties &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On January 30&lt;span style="vertical-align:super"&gt;th&lt;/span&gt;, 2024, the Company signed an agreement with a major shareholder for a $165,000 note payable. The note accrues interest at a rate of 1.75% compounded annually and has a maturity date of January 30, 2025 (Note 6 – Promissory and Convertible Notes). The note had interest expense of $728 and $1,930 for the three and nine months ended as of September 30, 2024, respectively. As of September 30, 2024, the Company had recorded accrued interest of $1,930 related to the note within accrued interest on the Condensed Consolidated Balance Sheet.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Mycotopia Consulting Agreement with the CEO&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On November 17, 2021, Mycotopia entered into an Executive Consulting Agreement (the “Mycotopia Consulting Agreement”), with Benjamin Kaplan (“BK”) to serve as the Company’s CEO for an initial term of 36 months. As of September 30, 2024 and December 31, 2023, the Company had cash compensation outstanding as accrued expense - related party due to the Mycotopia Consulting Agreement of $792,000 and $576,000, respectively. During the nine months ended September 30, 2024 and 2023, the Company recognized stock-based compensation of $0 and $635, respectively, from Warrants issued in connection with the Mycotopia Consulting Agreement. During the three months ended September 30, 2024 and 2023, the Company recognized stock-based compensation of $0 and $635, respectively, from Warrants issued in connection with the Mycotopia Consulting Agreement.  The Company records stock-based compensation on the consolidated income statement as general and administrative expense. &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Significant terms of the Mycotopia Consulting Agreement are as follows:&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="border-bottom:1px solid #000000"&gt;Annual Base Consulting Fee&lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Every calendar month the Company pays the CEO a consulting fee of $24,000, with an annual total fee of $288,000. &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;span style="border-bottom:1px solid #000000"&gt;Bonus Compensation Milestones &lt;/span&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The CEO was granted a Warrant to purchase that number of shares of Mycotopia common stock equal to 5% of the issued and outstanding Mycotopia common shares, on a fully diluted basis. The Warrant had an exercise price of $0.01 per share and expired on November 16, 2023.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;During the year ended December 31, 2023, the Company issued 1,922 vested Mycotopia warrant shares in accordance with the Warrant valued at $635 (see Note 7 – Stockholders’ Equity).&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;  &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The Company will pay the CEO a bonus in Mycotopia restricted stock or restricted stock units based on the following EBITDA milestones. As of September 30, 2024, no EBITDA milestones were met, and no amounts have been recorded for the bonus milestones.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td colspan="2" style="width:29.88%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Bonus &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.98%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.98%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:66.16%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;EBITDA Milestones &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:3.98%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:25.88%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;100,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:66.16%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;1&lt;span style="vertical-align:super"&gt;st &lt;/span&gt;$1,000,000&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:3.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:25.88%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;100,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:66.16%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;2&lt;span style="vertical-align:super"&gt;nd &lt;/span&gt;$1,000,000&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:3.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:25.88%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;100,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:66.16%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;3&lt;span style="vertical-align:super"&gt;rd &lt;/span&gt;$1,000,000&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:3.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:25.88%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;100,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:66.16%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;4&lt;span style="vertical-align:super"&gt;th &lt;/span&gt;$1,000,000&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:3.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:25.88%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;100,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:66.16%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;5&lt;span style="vertical-align:super"&gt;th &lt;/span&gt;$1,000,000&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin-top:0pt;margin-bottom:8pt;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The Company will pay the CEO a bonus in restricted stock or restricted stock units based on the following Mycotopia market capitalization by maintaining the below market cap for Mycotopia for a period of 22 consecutive trading days:&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td style="width:30.88%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Bonus (Shares)&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="width:65.36%;border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Market Capitalization Milestone &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%;padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:30.88%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;250,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.12%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:63.26%;border-top:0.5pt solid #000000" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;30,000,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:30.88%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;250,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.12%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:63.26%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;40,000,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:30.88%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;250,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.12%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:63.26%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;60,000,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="width:30.88%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;250,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="width:2.12%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:63.26%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;80,000,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:30.88%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;250,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:2.12%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:63.26%" valign="middle"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt;100,000,000&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.26%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;i&gt;Stock Grants – Significant Transactions&lt;/i&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;Upon the Company closing a Significant Transaction, the CEO shall be granted shares of Mycotopia common stock or a new series of Mycotopia preferred shares that is convertible into Mycotopia common stock equal to 5% of the value of all the consideration, including any stock, cash or debt of such completed transaction. A “Significant Transaction” shall mean a financing of at least $500,000 or the closing of an acquisition with a valuation of at least $1,000,000 for Mycotopia. As of September 30, 2024 and December 31, 2023, the Company had not granted any shares in relation to a Significant Transaction.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;As of September 30, 2024 and December 31, 2023, there are no amounts accrued related to the bonuses.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Board Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;As of September 30, 2024 and December 31, 2023, the Company had accrued expenses from board compensation of $325,000 and $250,000, respectively. Accrued board compensation is included as part of Accounts payable and accrued expenses on the consolidated balance sheets.&lt;/p&gt;
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:DebtInstrumentMaturityDate id="f340" contextRef="c103">2023-09-27</us-gaap:DebtInstrumentMaturityDate>
  <tpia:ExchangeOfCommonStockForSeriesAPreferredStockShares id="f341" decimals="INF" contextRef="c37" unitRef="shares">1.0</tpia:ExchangeOfCommonStockForSeriesAPreferredStockShares>
  <us-gaap:SharesOutstanding id="f342" decimals="INF" contextRef="c104" unitRef="shares">14896791.0</us-gaap:SharesOutstanding>
  <us-gaap:NetIncomeLoss id="f343" decimals="128" contextRef="c85" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="f344" decimals="INF" contextRef="c68" unitRef="usd">-278682.0</us-gaap:NetIncomeLoss>
  <us-gaap:PreferredStockSharesIssued id="f345" decimals="INF" contextRef="c4" unitRef="shares">1.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:StockholdersEquity id="f346" decimals="INF" contextRef="c65" unitRef="usd">14857.0</us-gaap:StockholdersEquity>
  <tpia:ExchangeOfCommonStockForSeriesAPreferredStockShares id="f347" decimals="INF" contextRef="c69" unitRef="shares">-9793754.0</tpia:ExchangeOfCommonStockForSeriesAPreferredStockShares>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="f348" decimals="INF" contextRef="c11" unitRef="shares">1542502.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:IntangibleAssetsNetIncludingGoodwill id="f349" decimals="INF" contextRef="c105" unitRef="usd">2000000.0</us-gaap:IntangibleAssetsNetIncludingGoodwill>
  <us-gaap:StockholdersEquity id="f350" decimals="INF" contextRef="c106" unitRef="usd">-8361320.0</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="f351" decimals="INF" contextRef="c61" unitRef="shares">14896791.0</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity id="f352" decimals="INF" contextRef="c107" unitRef="usd">6917776.0</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="f353" decimals="INF" contextRef="c108" unitRef="usd">-7779634.0</us-gaap:StockholdersEquity>
  <us-gaap:ConvertibleNotesPayable id="f354" decimals="INF" contextRef="c99" unitRef="usd">220000.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:NetIncomeLoss id="f355" decimals="INF" contextRef="c17" unitRef="usd">-890386.0</us-gaap:NetIncomeLoss>
  <us-gaap:AdditionalPaidInCapital id="f356" decimals="INF" contextRef="c16" unitRef="usd">6917774.0</us-gaap:AdditionalPaidInCapital>
  <us-gaap:ConvertibleNotesPayable id="f357" decimals="128" contextRef="c48" unitRef="usd">0.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:StockholdersEquity id="f358" decimals="128" contextRef="c55" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="f359" decimals="INF" contextRef="c109" unitRef="usd">6917776.0</us-gaap:StockholdersEquity>
  <us-gaap:NetIncomeLoss id="f360" decimals="128" contextRef="c110" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f361" decimals="INF" contextRef="c41" unitRef="usd1">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:ConvertibleNotesPayableCurrent id="f362" decimals="INF" contextRef="c16" unitRef="usd">1090651.0</us-gaap:ConvertibleNotesPayableCurrent>
  <us-gaap:NetIncomeLoss id="f363" decimals="128" contextRef="c111" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:ConvertibleNotesPayable id="f364" decimals="INF" contextRef="c101" unitRef="usd">325000.0</us-gaap:ConvertibleNotesPayable>
  <us-gaap:NonoperatingIncomeExpense id="f365" decimals="INF" contextRef="c7" unitRef="usd">-74887.0</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:AccruedLiabilitiesCurrent id="f366" decimals="INF" contextRef="c25" unitRef="usd">449587.0</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f367" decimals="INF" contextRef="c20" unitRef="usd1">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:UseOfEstimates id="f368" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The preparation of financial statements in conformity with U.S GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Our financial statements include, when applicable, disclosures of estimates, assumptions, uncertainties, and markets that could affect our financial statements and future operations.&lt;/p&gt;
</us-gaap:UseOfEstimates>
  <dei:EntityAddressAddressLine1 id="f369" contextRef="c">100 SE 2nd Street</dei:EntityAddressAddressLine1>
  <us-gaap:PreferredStockSharesAuthorized id="f370" decimals="INF" contextRef="c41" unitRef="shares">1500000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized id="f371" decimals="INF" contextRef="c20" unitRef="shares">1500000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:NetIncomeLoss id="f372" decimals="INF" contextRef="c62" unitRef="usd">-470675.0</us-gaap:NetIncomeLoss>
  <tpia:NetLossPerShareBasicAndDiluted id="f373" decimals="INF" contextRef="c" unitRef="usd1">-0.11</tpia:NetLossPerShareBasicAndDiluted>
  <us-gaap:PreferredStockSharesIssued id="f374" decimals="INF" contextRef="c41" unitRef="shares">0.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:DebtInstrumentMaturityDate id="f375" contextRef="c112">2024-01-21</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:InterestExpense id="f376" decimals="INF" contextRef="c" unitRef="usd">219222.0</us-gaap:InterestExpense>
  <us-gaap:OperatingExpenses id="f377" decimals="INF" contextRef="c" unitRef="usd">1137539.0</us-gaap:OperatingExpenses>
  <us-gaap:NetIncomeLoss id="f378" decimals="128" contextRef="c53" unitRef="usd">0.0</us-gaap:NetIncomeLoss>
  <us-gaap:IncomeTaxesPaid id="f379" decimals="128" contextRef="c17" unitRef="usd">0.0</us-gaap:IncomeTaxesPaid>
  <us-gaap:PreferredStockSharesIssued id="f380" decimals="INF" contextRef="c20" unitRef="shares">0.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock id="f381" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Organization and Business Activity&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The Company was incorporated in Nevada on January 21, 2000, under the name RM Investors, Inc. In December 2020, we entered into definitive agreements with Ehave, Inc., an Ontario corporation (“Ehave”), Mycotopia Therapies Inc., a Florida corporation and wholly owned subsidiary of Ehave (“MYC”), and the former and current directors of 20/20 Global that provide for: (i) 20/20 Global’s purchase for $350,000 in cash of all of the outstanding stock of MYC from Ehave under a Stock Purchase Agreement, resulting in MYC becoming a wholly owned subsidiary of 20/20 Global; and (ii) the change of control of 20/20 Global’s board of directors and management under a Change of Control and Funding Agreement. In a related transaction, Ehave agreed to purchase 9,793,754 shares of 20/20 Global common stock, which constitute approximately 75.77% of the then-issued and outstanding shares of 20/20 Global’s common stock, for $350,000 in cash through a Stock Purchase Agreement (“MYC SPA”) with 20/20 Global stockholders Mark D. Williams, Colin Gibson, and The Robert and Joanna Williams Trust. As of September 30, 2024 Ehave owned one share of Series A Preferred Stock which granted it a voting interest of 75% of all votes for matters presented for stockholder vote to the stockholders of the Corporation&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On January 19, 2021, the above transaction closed. Because the former shareholder of Mycotopia Therapies, Inc. acquired 75.77% of the Company’s then-outstanding stock and there was a change in control of the board of directors, the transaction was accounted for as a reverse merger in which Mycotopia Therapies, Inc. was deemed to be the accounting acquirer and the Company the legal acquirer. Subsequent to the transaction, the Company changed its name from 20/20 Global, Inc. to Mycotopia Therapies, Inc.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;As a result of the transaction, the historical consolidated financial statements of the Company for periods prior to the date of the transaction are those of Mycotopia Therapies, Inc., as the accounting acquirer, and all references to the consolidated financial statements of the Company apply to the historical financial statements of Mycotopia Therapies, Inc. prior to the transaction and the consolidated financial statements of the Company subsequent to the transaction.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On November 17, 2023, the Company created a new Florida-based subsidiary, NPD Genius, LLC (“NPD”).  &lt;/p&gt;
</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="f382" decimals="INF" contextRef="c9" unitRef="usd">-308700.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:PreferredStockSharesOutstanding id="f383" decimals="INF" contextRef="c41" unitRef="shares">0.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod id="f384" decimals="128" contextRef="c" unitRef="shares">0.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses id="f385" decimals="128" contextRef="c26" unitRef="usd">0.0</tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpenses>
  <us-gaap:PrepaidExpenseCurrent id="f386" decimals="INF" contextRef="c25" unitRef="usd">700.0</us-gaap:PrepaidExpenseCurrent>
  <dei:EntityAddressAddressLine2 id="f387" contextRef="c">Suite 2000</dei:EntityAddressAddressLine2>
  <us-gaap:PreferredStockSharesOutstanding id="f388" decimals="INF" contextRef="c20" unitRef="shares">0.0</us-gaap:PreferredStockSharesOutstanding>
  <tpia:ConvertibleDebtInterest id="f389" decimals="INF" contextRef="c99" unitRef="usd">89089.0</tpia:ConvertibleDebtInterest>
  <tpia:IncreaseDecreaseInAccruedExpensesRelatedParty id="f390" decimals="INF" contextRef="c17" unitRef="usd">216000.0</tpia:IncreaseDecreaseInAccruedExpensesRelatedParty>
  <tpia:ConvertibleDebtOutstanding id="f391" decimals="INF" contextRef="c25" unitRef="usd">1714587.0</tpia:ConvertibleDebtOutstanding>
  <tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShare id="f392" decimals="INF" contextRef="c24" unitRef="shares">378582.0</tpia:CommonStockIssuedToSettleAccountsPayableAndAccruedExpensesShare>
  <tpia:ConvertibleDebtOutstanding id="f393" decimals="INF" contextRef="c15" unitRef="usd">78671.0</tpia:ConvertibleDebtOutstanding>
  <tpia:DueToRelatedParties id="f394" decimals="INF" contextRef="c25" unitRef="usd">165000.0</tpia:DueToRelatedParties>
  <us-gaap:StockholdersEquity id="f395" decimals="INF" contextRef="c104" unitRef="usd">14895.0</us-gaap:StockholdersEquity>
  <us-gaap:IncomeTaxExpenseBenefit id="f396" decimals="128" contextRef="c9" unitRef="usd">0.0</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:StockholdersEquity id="f397" decimals="128" contextRef="c57" unitRef="usd">0.0</us-gaap:StockholdersEquity>
  <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock id="f398" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"&gt; &lt;/p&gt;
&lt;table style="border-collapse:collapse;width:100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;For the Year Ended,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td colspan="2" style="border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;&lt;b&gt; &lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;width:77.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Remainder of 2024&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.98%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1.06%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:17.98%;border-top:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;167,883&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;width:1%" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;2025&lt;/p&gt;
&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;666,058&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;2026&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;605,839&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Thereafter&lt;/p&gt;
&lt;/td&gt;&lt;td style="padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="border-bottom:0.5pt solid #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;-&lt;/p&gt;
&lt;/td&gt;&lt;td style="padding-bottom:1.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td style="background-color:#CCEEFF;padding-bottom:2.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;Total remaining amortization expense&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;padding-bottom:2.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt;$&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom"&gt;&lt;p style="font:11pt stHtmlOvrFontNm;margin:0;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;1,439,781&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;&lt;td style="background-color:#CCEEFF;padding-bottom:2.5pt" valign="bottom"&gt;&lt;p style="font:10pt stHtmlOvrFontNm;margin:0"&gt; &lt;/p&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="f399" decimals="INF" contextRef="c113" unitRef="usd">325000.0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <tpia:NetLossPerShareBasicAndDiluted id="f400" decimals="INF" contextRef="c9" unitRef="usd1">-0.02</tpia:NetLossPerShareBasicAndDiluted>
  <tpia:ConvertibleDebtInterest id="f401" decimals="INF" contextRef="c101" unitRef="usd">50504.0</tpia:ConvertibleDebtInterest>
  <tpia:ExchangeOfCommonStockForSeriesAPreferredStock id="f402" decimals="INF" contextRef="c69" unitRef="usd">-9794.0</tpia:ExchangeOfCommonStockForSeriesAPreferredStock>
  <dei:EntityCurrentReportingStatus id="f403" contextRef="c">Yes</dei:EntityCurrentReportingStatus>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="f404" decimals="INF" contextRef="c114" unitRef="usd">250000.0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="f405" decimals="INF" contextRef="c17" unitRef="usd">141490.0</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IntangibleAssetsNetIncludingGoodwill id="f406" decimals="INF" contextRef="c25" unitRef="usd">1439781.0</us-gaap:IntangibleAssetsNetIncludingGoodwill>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock id="f407" contextRef="c">&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;NOTE 7 – STOCKHOLDERS’ EQUITY&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;As of December 31, 2023, the Company was authorized to issue 5,000,000 shares of its preferred stock in one or more series, of which 1,500,000 were designated “Series B Preferred Stock”. On June 24, 2024, the Board of Directors of the Company approved the designation of one share of preferred stock as “Series A Preferred Stock”. As of September 30, 2024, the Company was authorized to issue 5,000,000 shares of preferred stock, of which 1,500,000 were designated “Series B Preferred Stock” and 1 was designated “Series A Preferred Stock”.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;As of September 30, 2024 and December 31, 2023 we were authorized to issue 467,000,000 and 100,000,000 shares of common stock, respectively. On June 24, 2024, the Board of Directors of the Company approved an increase in the authorized shares of common stock from 100,000,000 to 467,000,000.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Common Stock &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;As of September 30, 2024 and December 31, 2023 we were authorized to issue 467,000,000 and 100,000,000 shares of common stock, respectively. Each share of common stock has a $0.001 par value. Each share of common stock entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. The Company had 5,481,619 and 14,896,791 shares of common stock issued and outstanding as of September 30, 2024, and December 31, 2023, respectively.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;During the year ended December 31, 2023, the Company issued 38,434 shares of common stock to settle $43,750 of accrued expenses. There was no gain or loss recorded on the issuance of the shares (Note 8 – Stock Based Compensation).&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On July 29, 2024, the Company entered into an Exchange Agreement with Ehave, Inc., its largest shareholder, whereby Ehave, Inc. exchanged 9,793,754 shares of common stock for one share of Series A Preferred Stock.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On September 23, 2024, the Company issued 378,582 shares of common stock to settle $26,250 of accrued expenses. There was no gain or loss recorded on the issuance of the shares (Note 8 – Stock Based Compensation).&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Series A Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;As of September 30, 2024 and December 31, 2023 we were authorized to issue 1 and 0 shares of Series A Preferred Stock, $0.001 par value. The holder of the Series A Preferred is entitled to cast that number of votes on all matters presented for stockholder vote to the stockholders of the Corporation that when taking into account the votes entitled to be cast by the Series A Preferred stockholder is equal to seventy-five percent (75%) of the total shares authorized to vote on such matter(s) and such holder shall vote along with holders of the Corporation’s Common Stock on such matters. Additionally, the Series A Preferred Stock is convertible into 9,793,754 shares of Company common stock at the option of the holder. &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;On July 29, 2024, the Company entered into an Exchange Agreement with Ehave, Inc., its largest shareholder, whereby the Company agreed to issue Ehave, Inc. one share of Series A Preferred Stock in exchange for 9,793,754 shares of common stock.&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin-top:0pt;margin-bottom:8pt;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;&lt;b&gt;&lt;i&gt;Series B Preferred Stock - Mezzanine Equity&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt; &lt;/p&gt;
&lt;p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"&gt;The Series B Preferred Stock is recorded as mezzanine equity in accordance with ASC 480, “&lt;i&gt;Distinguishing Liabilities from Equity&lt;/i&gt;”. The Series B Shares are recorded as mezzanine equity in accordance with ASC 480 because the Company may be obligated to issue a variable number of shares at a fixed price known at inception and there is no maximum number of shares that could potentially be issued upon conversion. In this instance, cash settlement would be presumed and the Series B Shares are classified as mezzanine equity in accordance with ASC 480-10-S99. Immediately upon effectiveness of the registration statement registering for resale of all the common stock issuable under the Series B Shares, all outstanding Series B Shares shall automatically convert into common stock. As of September 30, 2024 and December 31, 2023 the Company was authorized to issue 1,500,000 shares of Series B Preferred Stock.&lt;/p&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod id="f408" decimals="INF" contextRef="c" unitRef="shares">333333.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo id="f409" decimals="INF" contextRef="c25" unitRef="usd">666058.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
</xbrli:xbrl>
